logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Kushengtang (02273.HK) spent 14.4424 million Hong Kong dollars to repurchase 500,000 shares on November 21st.

date
21/11/2025
Tiger Brokers Finance App News, Gu Sheng Tang (02273.HK) announced that the company spent 14.4424 million Hong Kong dollars on November 21, 2025 to repurchase 500,000 shares, with a repurchase price per share of 28.48-29.18 Hong Kong dollars.
Latest
1 m ago
Southbound Holdings (01982.HK) will distribute an interim dividend of HK$0.11 per share on December 19th.
1 m ago
(01240) appointed Zhou Lu as an independent non-executive director.
2 m ago
Hengrui Medicine (01276.HK) has repurchased a total of 8.8987 million A-shares as of November 21st.
2 m ago
Chairman Tang Weikun of the board of directors increased his holdings of Yuanda Pharmaceutical (00512.HK) by 50,000 shares at a price of 8.28 Hong Kong dollars per share.
2 m ago
Tianyue Technology: Shareholders holding more than 5% of the shares reduce their holdings by 9.5491 million shares, cashing out 747 million yuan.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.